Work

A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer

Year: 2025

Type: article

Study design: Clinical Trial

Source: American Journal of Clinical Oncology

DOI: 10.1097/coc.0000000000001263

Authors: Aminah Jatoi, Nathan R. Foster, Andrea Wahner Hendrickson, Matthew S. Block, S. John Weroha, Erik J. Asmus, Nicole R. Murray, Alan P. Fields

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415355874

FWCI: 2.1

Cites: 13

Cited by: 3

Related to: